Abbott Low Dose Kaletra Tablet Clears FDA For Pediatric HIV Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Lower strength tablet formulation will be available at half the cost of full strength tablet in developing countries, according to Abbott.